Evidence map›Paper›PMID 41267454›Full record

SynthesisAddiction (Abingdon, England)2026

Drug use among people in prison: A global review of epidemiology, harms and interventions.

Louis Favril, John Strang, Seena Fazel

Abstract readSystematic Review
In one paragraph

Synthesis in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Louis FavrilDepartment of Criminology, Criminal Law and Social Law, Ghent University, Ghent, Belgium.ORCID https://orcid.org/0000-0002-9519-7824
John StrangNational Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0002-5413-2725
Seena FazelDepartment of Psychiatry, Oxford University, Oxford, UK.ORCID https://orcid.org/0000-0002-5383-5365

Funding

Research Foundation-Flanders 1247123N
6 · The paper itself

Abstract

BACKGROUND AND

aimsPeople who use drugs are overrepresented in the criminal justice system. We aimed to provide a broad synthesis of the epidemiology, harms and interventions related to drug use and drug use disorders among incarcerated adults worldwide, and highlight gaps in evidence and practice.

methodsIn this structured review, we searched PubMed and Web of Science for articles published between 2015 and August 2025. Systematic reviews, meta-analyses and large primary studies with unselected samples were given preference for inclusion.

resultsFour in ten adults who enter prison meet diagnostic criteria for a drug use disorder, a treatable psychiatric condition often underlying the offences that led to their incarceration. Drug use disorders are approximately ten times more prevalent among people in prison compared with the general population, with a higher excess in women. Comorbid mental disorders are common. Around a third of incarcerated individuals report using drugs during imprisonment, which poses a health and safety risk for people both living and working in prisons. Injecting drug use in prison contributes to blood-borne virus transmission. In addition to its strong link with recidivism, drug use is associated with a markedly increased risk of premature mortality after release from prison, particularly from drug-related causes within the first two weeks post-release. Despite robust evidence supporting the effectiveness of prison-based pharmacological (e.g. opioid agonist treatment) and psychosocial (e.g. therapeutic communities) interventions in reducing drug-related harms, there remains a significant treatment gap within prison settings worldwide. Further research is needed to assess the health benefits of harm reduction services in prisons, including needle and syringe programmes. Strategies to facilitate linkage to and retention in post-release services are key to ensure continuity of care and achieve sustainable treatment outcomes.

conclusionThe high prevalence of drug use and its multiple adverse outcomes among people in prison underscore the need for provision of evidence-based interventions. Expanding and integrating prison-based and post-release interventions to address drug use has the potential to yield both public health and criminal justice benefits.

Indexed as

PrisonersSubstance-Related DisordersAdultFemaleGlobal HealthHarm ReductionHumansMaleMental DisordersPrevalencePrisonsSubstance Abuse, Intravenouscomorbiditydrug dependenceincarcerationinjecting drug usejailoverdoserecidivism

Identifiers

PMID41267454
PMCPMC12980310

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.